Pioneering oral medicines for inflammatory disease
Trotana is a biotechnology company
developing novel oral anti-inflammatory medicines
to clinically-validated mechanisms
We are experts in RNA binding proteins and are passionate about developing new therapeutic options for patients suffering with inflammatory disease. Our RNA binding protein modulator engine (RiME) is uniquely positioned to develop orally-dosed small molecule therapeutics targeting the human transcriptome. Trotana is focused on advancing our proprietary pipeline of RiME-generated therapeutics to clinically-validated immunology mechanisms.
Lorem ipsum dolor sit amet, consectetur adipiscing elit seddo
Our deep expertise in RNA binding proteins (RBPs) enables Trotana to pioneer the development of therapeutics targeting the human immune transcriptome. Our RNA binding protein modulator engine (RiME) synergizes RBP biology and small molecule discovery to generate orally-dosed drugs against nodal RBPs controlling human immune function.
Latest News
Lorem ipsum dolor sit amet, consectetur adipiscing elit seddo
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut... ...
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
